ARCH Venture Fund IX, L.P. 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:55 pm Purchase |
2024-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
ARCH Venture Fund IX, L.P. | 36,597,716 13.100% |
120,000 (+0.33%) |
Filing |
| 2024-02-14 3:18 pm Purchase |
2023-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
ARCH Venture Fund IX, L.P. | 36,477,716 14.500% |
65,000 (+0.18%) |
Filing |
| 2022-02-14 12:04 pm Purchase |
2021-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
ARCH Venture Fund IX, L.P. | 36,412,716 15.100% |
36,412,716 (New Position) |
Filing |